Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Cardio Diagnostics Holdings Inc. - Common stock (NQ:CDIO)

3.800 +0.120 (+3.26%)
Streaming Delayed Price Updated: 1:00 PM EDT, Jul 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Cardio Diagnostics Holdings Inc. - Common stock

< Previous 1 2 3 Next >
Beyond Diagnosis: Cardio Diagnostics' Actionable Clinical Intelligence Platform Provides Personalized Insights To Help Prevent Heart Attacks
By Jeremy Golden, Benzinga 
Via TheNewswire.com
Cardio Diagnostics Holdings, Inc. Announces the Grant of a Patent in India
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
CORRECTING and REPLACING Cardio Diagnostics Holdings, Inc. Unveils Groundbreaking Employer Cardiovascular Disease Risk Intelligence Platform, HeartRisk™
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
American Medical Association (AMA) Grants Cardio Diagnostics a Dedicated CPT PLA Reimbursement Code for Epi+Gen CHD, an AI-powered Test for Assessing the Probability of a Heart Attack or Coronary Heart Disease Event
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
American Medical Association (AMA) Grants Cardio Diagnostics Holdings, Inc.’s AI-Powered Coronary Heart Disease Detection Test, PrecisionCHD, a Dedicated CPT PLA Reimbursement Code
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
Cardio Diagnostics Holdings, Inc. Appoints Biotechnology Investor, Executive & Serial Entrepreneur Paul Burton to its Board of Directors
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
Cardio Diagnostics’ Breakthrough Coronary Heart Disease Detection Test Published In The Journal Of The American Heart Association
By Jeremy Golden, Benzinga 
Via TheNewswire.com
Cardio Diagnostics Holdings, Inc. Regains Nasdaq Minimum Bid Price Requirement
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
CORRECTING and REPLACING Cardio Diagnostics Holdings, Inc. Convenes Cardiovascular Care & Risk Roundtable at the 42nd Annual J.P. Morgan Healthcare Conference
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
American Medical Association is Reviewing Cardio Diagnostics Holdings, Inc’s Integrated Epigenetic-Genetic Cardiovascular Medicine Tests for CPT PLA Codes
From Cardio Diagnostics Holdings
Via Business Wire
Cardio Diagnostics Establishes A New Partnership To Facilitate Global Footprint And Expansion Beyond North America With India-Based Aimil Ltd.
By Jeremy Golden, Benzinga 
Via TheNewswire.com
Topics Death
Cardio Diagnostics Holdings, Inc. Announces Breakthrough in Coronary Heart Disease Detection with PrecisionCHD Test, Published in the Journal of the American Heart Association
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
With New Lab/Operations Hub, Cardio Diagnostics Says it’s Prepared To Meet Uptake In Demand, Announces New Partner Initiative
By Jeremy Golden, Benzinga 
Via TheNewswire.com
Family Medicine Specialists Selects Cardio Diagnostics’ Epigenetic-Genetic Tests for Assessing Heart Attack Risk for its BlueCross BlueShield Patients
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
Cardio Diagnostics Leverages AI To Combat Cardiovascular Disease
By Jeremy Golden, Benzinga 
Via TheNewswire.com
Topics Artificial Intelligence Death
Cardio Diagnostics Holdings, Inc Receives Innovative Technology Contract from Vizient for Its Novel AI-Driven Precision Heart Disease Tests – Epi+Gen CHD & PrecisionCHD
From Cardio Diagnostics Holdings, Inc
Via Business Wire
Cardio Diagnostics Holdings, Inc and Aimil Ltd Join Forces to Introduce Cardiovascular Epigenetic Technologies to India
From Cardio Diagnostics Holdings, Inc
Via Business Wire
Cardio Diagnostics Holdings, Inc Launches New Lab and Fulfillment Center, Paving Way for Expanded Testing Capacity, Reduced Costs, Reduced Turnaround Time and Improved Margins
From Cardio Diagnostics Holdings, Inc
Via Business Wire
Cardio Diagnostics Publishes Novel and Scalable Pathways to Enhance Global Coronary Heart Disease Care through Precision Epigenetics in Epigenomics
From Cardio Diagnostics Holdings, Inc
Via Business Wire
Cardio Diagnostics Holdings, Inc. and Truckers Health Network Enter Into a Strategic Collaboration to Accelerate Cardiovascular Health Initiatives in the Trucking Industry
From Cardio Diagnostics Holdings, Inc
Via Business Wire
Cardio Diagnostics Holdings, Inc Partners with Ascension Borgess Hospital’s Heart Attack Prevention Clinic on Coronary Artery Disease Study
From Cardio Diagnostics Holdings, Inc
Via Business Wire
Cardio Diagnostics Holdings, Inc to Participate in Upcoming Investor Conferences
From Cardio Diagnostics Holdings, Inc
Via Business Wire
Cardio Diagnostics Partners With FRSTeam of East Kansas and West Missouri to Host First Onsite Heart Disease Fair in Kansas Using Epigenetic-Genetic Technologies
From Cardio Diagnostics Holdings, Inc
Via Business Wire
Cardio Diagnostics Holdings, Inc Announces Expansion of IP Portfolio in Australia with Notice of Allowance of Patent Application
From Cardio Diagnostics Holdings, Inc
Via Business Wire
Cardio Diagnostics Holdings, Inc and RiverRock Medical Partner to Bring Epigenetic-Genetic Heart Disease Testing to Austin, Texas
From Cardio Diagnostics Holdings, Inc
Via Business Wire
Cardio Diagnostics Holdings, Inc Democratizes CHD Detection with Nationwide Launch of PrecisionCHD™
From Cardio Diagnostics Holdings, Inc
Via Business Wire
Cardio Diagnostics Publishes Research Highlighting the Reversibility of Epigenetic Signatures of Coronary Heart Disease
From Cardio Diagnostics Holdings, Inc
Via Business Wire
Cardio Diagnostics Holdings, Inc’s Actionable Clinical IntelligenceTM (ACI) Platform Offers New Epigenetic and Genetic Insights to Inform Coronary Heart Disease Management
From Cardio Diagnostics Holdings, Inc
Via Business Wire
Transforming Heart Disease Prevention for Self-Insured Employers in Oklahoma, Missouri, Kansas, and Arkansas: A Strategic Alliance between Connect Clinic and Cardio Diagnostics
From Cardio Diagnostics Holdings, Inc
Via Business Wire
Cardio Diagnostics Holdings, Inc Unveils The CardioInnovate360TM BioPharma Research System
From Cardio Diagnostics Holdings, Inc
Via Business Wire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.